🇺🇸 FDA
Pipeline program

Enekinragene Inzadenovec (PCRX-201)

201-C-201

Phase 2 mab active

Quick answer

Enekinragene Inzadenovec (PCRX-201) for Osteoarthritis (OA) of the Knee is a Phase 2 program (mab) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Osteoarthritis (OA) of the Knee
Phase
Phase 2
Modality
mab
Status
active

Clinical trials